Toshio Miyata, Norio Suzuki, Charles van Ypersele de Strihou 

Slides:



Advertisements
Similar presentations
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects  Chi Chen, Ah-Ng Tony Kong  Trends in Pharmacological.
Advertisements

Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a review Amma Owusu-Ansah 1, 2 ;Sung Hee Choi 1, 1_FMD OAA.
Signaling by Keap1/Nrf2 mediates the electrophile stress response
Signaling by Keap1/Nrf2 mediates the electrophile response
Kidney cancer: Identification of novel targets for therapy
Arne R. M. van der Bilt, Elisabeth G. E
Volume 76, Issue 9, Pages (November 2009)
Prolyl‐hydroxylase‐domain proteins regulate hypoxia inducible factor‐α in response to O2 availability. Prolyl‐hydroxylase‐domain proteins regulate hypoxia.
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Do reactive oxygen species play a role in myeloid leukemias?
Dylan Burger, Adeera Levin  Kidney International 
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease
Management of advanced renal cancer
ROS Function in Redox Signaling and Oxidative Stress
Hyun Gyu Lee, Hoon Young Choi, Jong-Sup Bae  Kidney International 
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Role of hypoxia in the pathogenesis of renal disease
Molecular mechanisms of diabetic renal hypertrophy
Hamid R. Rezvani, Nsrein Ali, Lars J
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Volume 93, Issue 1, Pages (January 2018)
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease  Stacey Ruiz, Pablo E. Pergola, Richard.
Figure 4 Mechanisms of leptin function on kidney injury
A “Reductionist” View of Cardiomyopathy
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
The SirT3 Divining Rod Points to Oxidative Stress
Volume 76, Issue 9, Pages (November 2009)
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Hypoxia-inducible factor pathway and diseases of the vascular wall
The Hypoxic Response: Huffing and HIFing
Y. Henrotin, Ph.D., B. Kurz, Ph.D., T. Aigner, M.D.DSc. 
Volume 70, Issue 7, Pages (October 2006)
Volume 107, Issue 1, Pages 1-3 (October 2001)
Sanjeev Noel, Abdel R.A. Hamad, Hamid Rabb  Kidney International 
Mechanism of steroid action in renal epithelial cells
Volume 82, Issue 11, Pages (December 2012)
Anemia management and chronic renal failure progression
Daniela Macconi, Giuseppe Remuzzi  Kidney International 
Regulation of intestinal epithelial gene expression in hypoxia
Into Thin Air: How We Sense and Respond to Hypoxia
A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles should.
Volume 70, Issue 10, Pages (November 2006)
Passing the baton: the HIF switch
Juliana Saraiva Anjos, MD, Ludmila F. M. F
Macrophages and hypoxia in human chronic kidney disease
Volume 83, Issue 4, Pages (April 2013)
Insight from the Air–Skin Interface
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Low oxygen stimulates the immune system
Volume 72, Issue 2, Pages (July 2007)
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
EMT and proteinuria as progression factors
Volume 61, Issue 2, Pages (February 2002)
The Duality of Angiogenesis: Implications for Therapy of Human Disease
Intratumoral hypoxia, radiation resistance, and HIF-1
New paradigms in cell death in human diabetic nephropathy
Volume 78, Issue 1, Pages (July 2010)
Angiotensin II: breathtaking in the renal medulla
Inflammation and hypoxia in the kidney: friends or foes?
Chapter 18 Dietary Phytochemicals in Neurodegenerative Disease
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
Volume 76, Issue 5, Pages (September 2009)
Volume 85, Issue 3, Pages (March 2014)
Volume 70, Issue 2, Pages (July 2006)
The Management of Diabetic Neuropathy in CKD
ROS: Really involved in Oxygen Sensing
High glucose and renin release: the role of succinate and GPR91
Sclerostin and DKK1: new players in renal bone and vascular disease
Presentation transcript:

Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?  Toshio Miyata, Norio Suzuki, Charles van Ypersele de Strihou  Kidney International  Volume 84, Issue 4, Pages 693-702 (October 2013) DOI: 10.1038/ki.2013.74 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Cellular defense mechanisms against hypoxia and oxidative stress (OS). (Upper panel) Prolylhydroxylase–hypoxia-inducible factor (PHD–HIF) pathway under hypoxia. HIF-α is constitutively transcribed and translated. Its level is primarily regulated by its rate of degradation. Oxygen determines its stability through its enzymatic hydroxylation by PHDs. Hydroxylated HIF-α is recognized by Hippel–Lindau tumor-suppressor protein (pVHL) and rapidly degraded by the proteasome. Nonhydroxylated HIF-α does not interact with pVHL and is thus stable. It binds to its heterodimeric partner HIF-α mainly in the nucleus and transactivates genes involved in the adaptation to hypoxic–ischemic stress. Expression of PHDs (PHD2 and PHD3) is regulated by HIF. PHDs interact with Siah1a/2 (PHD1 and PHD3) or FKBP38 (PHD2) and are subject to proteasomal degradation. PHD activity is inhibited under hypoxia or by nitric oxide, reactive oxygen species (ROS), transition metal chelators, cobalt chloride, 2-oxoglutarate analogs, or TM6008/TM6089. (Lower panel) Keap1–Nrf2 pathway under OS. Nrf2 is constitutively transcribed and translated. Its level is primarily regulated by its rate of degradation by Keap1. Under OS, reactive cysteines within the Keap1 moiety undergo conformational changes, eventually leading to detachment of Nrf2 from Keap1 and to inhibition of its ubiquitination. OS thus inhibits the degradation of Nrf2 and facilitates nuclear translocation of Nrf2. Nrf2 then heterodimerizes with a small Maf protein, binds to the antioxidant/electrophile-responsive element (ARE/EpRE), and transactivates a variety of antioxidant genes. GSH-Px2, glutathione peroxidase-2; HO-1, heme oxygenase-1; NQO1, NAD(P)H-quinone oxidoreductase 1; Nrf2, nuclear factor-erythroid 2 p45-related factor 2; VEGF, vascular endothelial growth factor. Kidney International 2013 84, 693-702DOI: (10.1038/ki.2013.74) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Relevance of REP cells to renal fibrosis. REP (renal erythropoietin (EPO)-producing) cells are peritubular interstitial cells distributing over all the renal cortex (top). An electron microscopic image of the interstitium of renal cortex is shown in the inlet picture: REP cells localized in a transgenic mouse between tubular epithelial cells (TECs) and vascular endothelial cells (ECs). Inflammatory signals in chronic kidney disease (CKD) transform REP cells into the myofibroblasts and deteriorate their EPO-producing ability (middle). In the early phase of renal fibrosis, REP cells may recover their initial nature through the correction of the inflammatory milieu. However, during prolonged CKD progression, the transformed REP cells are no longer able to regain their EPO-producing ability (bottom). Kidney International 2013 84, 693-702DOI: (10.1038/ki.2013.74) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Predicted binding modes by docking simulation computer study. (a) Oxygen sensor (human prolylhydroxylase-2 (PHD2)). TM6008 (blue), TM6089 (magenta), hypoxia-inducible factor (HIF) proline (orange), 2-oxoglutarate (light green), and Fe(II)(pink sphere) are shown. (b) Keap1 is depicted as a colored cartoon mode and an inhibitor molecule bound in the center of the concavity is shown by a space-filling model. Reprinted with permission from Miyata et al.24 Kidney International 2013 84, 693-702DOI: (10.1038/ki.2013.74) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 A broad range of anomalies associated with oxygen biology. Hypoxia, oxidative stress, and dyserythropoiesis have been implicated in chronic kidney disease (CKD). The prolylhydroxylase–hypoxia-inducible factor (PHD–HIF) system mitigates hypoxia whereas the Keap1–Nrf2 system does the same for oxidative stress. Under hypoxia, renal erythropoietin (EPO)-producing (REP) cells, originating from neural crests, transdifferentiate into myofibroblasts and contribute to renal fibrosis. The interrelationship between these pathways or factors may preclude the identification of a single culprit in the progression of CKD. Besides these oxygen-associated anomalies, many more pathways or factors involve and exacerbate renal injury. Recent findings in the fields of basic biology and of clinical medicine of diseases other than CKD suggest that agents interfering with the PHD-HIF system (e.g., PHD inhibitor, HIF activator) or the Keap1–Nrf2 system (e.g., Keap1 inhibitor, Nrf2 activator), or restoring the initial function of REP cells might retard renal fibrosis and progression of CKD. These hypothetical approaches require further testing in CKD. Kidney International 2013 84, 693-702DOI: (10.1038/ki.2013.74) Copyright © 2013 International Society of Nephrology Terms and Conditions